Bain Capital Private Equity Acquires Porus Labs

Novopor Advanced Science Acquires FAR Chemical from CPS Performance Materials Group

January 23, 2026

Manufacturing

Novopor Advanced Science, a Bain Capital–backed performance chemicals and materials CDMO, has acquired FAR Chemical from CPS Performance Materials Group to expand its U.S. footprint and add capabilities in complex specialty chemistries. The deal integrates FAR Chemical's expertise in custom and hazardous specialty chemical manufacturing—serving electronics, aerospace & defense, and coatings/adhesives end markets—into the Novopor platform.

OLAPLEX Acquires Purvala Bioscience

August 26, 2025

Biotechnology

Olaplex Holdings, Inc. has acquired Purvala Bioscience, a Boston-based biotech founded by Dr. Bradley Olsen that develops bioinspired molecules for health and beauty applications. The purchase — Olaplex's first acquisition since launching its brand over ten years ago — is intended to accelerate product innovation by combining Purvala’s molecular technologies with Olaplex’s patent-protected bond-building platform.

Novopor Advanced Science Acquires Pressure Chemical Company (PCC)

May 7, 2025

Data & Analytics

Novopor Advanced Science Private Limited, a Bain Capital portfolio company, announced it will acquire Pressure Chemical Company (PCC), an affiliate of the Minafin Group. The acquisition is intended to expand Novopor’s capabilities in high-pressure chemistry and complex specialty manufacturing and help build a more integrated specialty chemicals platform from development through commercial scale-up.

Bain & Company Acquires PiperLab

March 16, 2024

AI & Machine Learning

Bain & Company has acquired Madrid-based PiperLab, a provider of AI and machine learning solutions, to strengthen Bain's Advanced Analytics Group (AAG) and scale its technology and analytics capabilities across EMEA. PiperLab, founded in 2015, will form part of Bain’s AAG ecosystem and help deliver data-driven solutions to clients across industries including insurance, telecoms, utilities and logistics.

Bain Capital and Cinven to Acquire Lonza Specialty Ingredients

February 8, 2021

Manufacturing

Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.

Bain Capital Private Equity Acquires Majority Stake in Maesa

March 28, 2019

Consumer Products

Bain Capital Private Equity has signed a definitive agreement to acquire a majority stake in Maesa, a global beauty brand incubator and private-label manufacturer. Maesa’s co-founders and management remain substantial shareholders, while minority investor Andera Partners will be selling its stake; the deal positions Maesa for a next phase of global growth and capability expansion.